*Ipca Laboratories* disclosed a steep drop in standalone net profit for the quarter ended December 2008 due to forex losses to the tune of Rs.192.30 million and rise in interest cost.
During the quarter, the profit of the company declined 39.54% to Rs 231.80 million from Rs 383.40 million in the same quarter previous year. Net sales for the quarter rose 11.19% to Rs 3,133.10 million, while total income for the quarter rose 11.07% to Rs 3,136.30 million, when compared with the prior year period. The company posted earnings of Rs 9.24 a share during the quarter, registering 39.53% decline over previous year period. *Quarterly Results - Standalone (Rs in mn)* *As at* *Dec - 08* *Dec - 07* *%Change* *Net Sales* 3,133.10 2,817.90 11.19 *Net Profit* 231.80 383.40 (39.54) *Basic EPS* 9.24 15.28 (39.53) Interest cost increased 2.08 times to Rs 114.70 million while depreciation cost rose 27.31% to Rs 103.50 million over previous year period. The company has bought back 18,965 equity shares of Rs 10 each from open market purchase during the December quarter. The board of directors of the company has declared 2nd interim dividend of 30% at Rs.3 per share for the financial year 2008-09. --~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
